These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9764154)
21. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation]. Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420 [TBL] [Abstract][Full Text] [Related]
22. Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients. Bistrup C; Nielsen FT; Jeppesen UE; Dieperink H Nephrol Dial Transplant; 2001 Feb; 16(2):373-7. PubMed ID: 11158415 [TBL] [Abstract][Full Text] [Related]
23. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. Ho VC; Griffiths CE; Albrecht G; Vanaclocha F; León-Dorantes G; Atakan N; Reitamo S; Ohannesson A; Mørk NJ; Clarke P; Pfister P; Paul C Br J Dermatol; 1999 Aug; 141(2):283-91. PubMed ID: 10468801 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic equivalence and mg:mg switch ability of a generic cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients maintained on Sandimmun Neoral. Al Wakeel JS; Shaheen FA; Mathew MC; Abouzeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS Transplant Proc; 2008 Sep; 40(7):2252-7. PubMed ID: 18790206 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis. Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280 [TBL] [Abstract][Full Text] [Related]
27. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study. Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146 [TBL] [Abstract][Full Text] [Related]
28. Bioavailability of two oral formulations of cyclosporin A in uremic children before renal transplantation. Medeiros M; Gómez AC; Urizar JP; Campos-Sepúlveda AE; Saldaña IM; Ramírez LE; Romero NB; Velásquez JL; Castañeda-Hernández G; Muñoz R Pediatr Transplant; 1998 May; 2(2):145-9. PubMed ID: 10082447 [TBL] [Abstract][Full Text] [Related]
29. Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation. Coukell AJ; Plosker GL Pharmacoeconomics; 1998 Dec; 14(6):691-708. PubMed ID: 10346420 [TBL] [Abstract][Full Text] [Related]
30. UK multicentre study to assess the safety and tolerability of Neoral in stable renal transplant patients. UK Neoral Study Group. Moore RH Transpl Int; 1996; 9 Suppl 1():S311-3. PubMed ID: 8959853 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413 [TBL] [Abstract][Full Text] [Related]
32. Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study. Berth-Jones J; Henderson CA; Munro CS; Rogers S; Chalmers RJ; Boffa MJ; Norris PG; Friedmann PS; Graham-Brown RA; Dowd PM; Marks R; Sumner MJ Br J Dermatol; 1997 Apr; 136(4):527-30. PubMed ID: 9155952 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Reitamo S; Spuls P; Sassolas B; Lahfa M; Claudy A; Griffiths CE; Br J Dermatol; 2001 Sep; 145(3):438-45. PubMed ID: 11531834 [TBL] [Abstract][Full Text] [Related]
34. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524. Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008 [TBL] [Abstract][Full Text] [Related]
35. [Passage from sandimmun to neoral in kidney transplantation in children]. Broyer M; Maisin A; Guest G; Baudouin V; Charbit M; Reigneau O; Loirat C Arch Pediatr; 1999 Oct; 6(10):1066-9. PubMed ID: 10544781 [TBL] [Abstract][Full Text] [Related]
36. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study. Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540 [TBL] [Abstract][Full Text] [Related]
37. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral). Salek MS; Finlay AY; Lewis JJ; Sumner MI Qual Life Res; 2004 Feb; 13(1):91-5. PubMed ID: 15058791 [TBL] [Abstract][Full Text] [Related]
38. Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile. Meffert H; Bräutigam M; Färber L; Weidinger G Acta Derm Venereol; 1997 Mar; 77(2):137-41. PubMed ID: 9111826 [TBL] [Abstract][Full Text] [Related]
39. Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group. Offermann G; Korn A Transplant Proc; 1996 Aug; 28(4):2204-6. PubMed ID: 8769201 [No Abstract] [Full Text] [Related]
40. Clinical development of a cyclosporine microemulsion in transplantation. Kovarik JM; Mueller EA; Niese D Ther Drug Monit; 1996 Aug; 18(4):429-34. PubMed ID: 8857563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]